Keybanc Maintains Overweight on Steris, Raises Price Target to $265
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Brett Fishbin maintains an Overweight rating on Steris (NYSE:STE) and raises the price target from $255 to $265.
September 03, 2024 | 2:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst Brett Fishbin has maintained an Overweight rating on Steris and increased the price target from $255 to $265, indicating a positive outlook on the stock.
The increase in price target from $255 to $265 by Keybanc suggests a positive outlook for Steris, likely leading to a short-term increase in stock price as investors react to the analyst's confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100